First, we assessed if the frequency of p27+ cells is also associated with mammary tumor risk in rats by immunofluorescence analysis of mammary glands of E2-induced mammary cancer-susceptible ACI and resistant BN rats, without and after three weeks of E2 treatment. The gene discussed is CDKN1B; the disease is breast cancer.